VaramirStart free · no cardSign in
DMAC as of Oct 31 · 09:04 ET
DMACNasdaqPharmaceutical Preparations

DiaMedica Therapeutics Inc. · Brief

Next report

11 days

Nov 11 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±27.9%
avg realized
±6.4%
Nov 13 '24±60.1%▼−3.29%×0.05
Mar 17 '25±21.0%▼−13.02%×0.62
May 13 '25±38.7%▲+0.50%×0.01
Aug 12 '25±8.9%▲+14.94%×1.68
Q3 FY25±19.8%▼−14.10%×0.71
Q1 FY26±22.1%▲+1.96%×0.09
May 6 '26±36.3%▲+0.15%×0.00
Q2 FY26±15.9%▲+3.31%×0.21
quarterimplied−65%0+65%realized×
Q2 FY26±15.9%▲+3.31%×0.21
May '26±36.3%▲+0.15%×0.00
Q1 FY26±22.1%▲+1.96%×0.09
Q3 FY25±19.8%▼−14.10%×0.71
Aug '25±8.9%▲+14.94%×1.68
May '25±38.7%▲+0.50%×0.01
2 older reports
Mar '25±21.0%▼−13.02%×0.62
Nov '24±60.1%▼−3.29%×0.05
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2 of 3

+24.69%shares held by the ten largest reporting managers increased over the latest quarter13F · Jun 30 '26
11managers whose positions together make up four fifths of reported value13F · Jun 30 '26

Bear2

7 of 8recent reports where the move came in under the options implied rangeEarnings history
3 of 21largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

DMAC report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±20.6% into Nov 11 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.